i-spy 2: immunotherapy biomarkers in early breast cancer
Published 10 months ago • 183 plays • Length 7:26Download video MP4
Download video MP3
Similar videos
-
2:15
i-spy2.2: emerging biomarkers in breast cancer
-
1:46
i-spy 2: advancing outcomes high-risk breast cancer through adapting therapies
-
2:39
the role of biomarkers in guiding treatment for early-stage breast cancer
-
0:55
prognostic biomarkers of immunotherapy efficacy in breast cancer
-
1:03
immunotherapy biomarkers in neoadjuvant breast cancer
-
1:55
predictive biomarkers in breast cancer
-
1:03
elucidating immunotherapy biomarkers for breast cancer
-
16:14
cancer early detection & interception panel part 4: i-spy 2 - breast cancer treatment
-
6:45
innovative biomarker approaches in breast cancer therapy
-
3:39
foxc1 as a novel prognostic biomarker in immune checkpoint inhibitor therapy
-
0:58
dr. esserman discusses the i-spy 2 trial in breast cancer
-
1:45
identifying novel predictive biomarkers in breast cancer
-
6:08
prognostic biomarkers in breast cancer – the latest developments
-
1:39
using single cell technologies to identify biomarkers for breast cancer patient outcomes
-
3:17
multiplexed analysis and spatial histology to predict response to immunotherapy in breast cancer
-
2:05
immunotherapy in breast cancer
-
1:56
dr. esserman on the elements of the i-spy 2 trial in breast cancer
-
1:43
composite biomarkers predictive of palbociclib endocrine treatment benefit in early breast cancer
-
0:56
gut microbiome and treatment outcomes in hr /her2- breast cancer